Please select the option that best describes you:
Topics:
Head and Neck Cancers • Radiation Oncology
When, if at all, do you use nasolacrimal duct stents to prevent stenosis/obstruction when treating skin, sinonasal, or other mid-facial H&N cancers with radiation therapy?
If so, what is your selection criteria? How long do they remain in place?
Do you have any dose constraints to the nasolacrimal duct?
Answer from: Radiation Oncologist at Academic Institution
I don’t because when the stent is removed, the duct stenoses.
Sign in or Register to read more